Citations

Clear

26 citation(s) found for "Lee, Jennifer".

Neurological complications, neuromonitoring, and outcomes in extracorporeal membrane oxygenation: Venovenous versus venoarterial support – A comprehensive review
Sakusic, Amra, lee, jennifer, Kenneth, R Seid, Ortoleva, J P, Martin, Nathaniel, Vollmer, Nicholas , Ramanujan, Krishnan S. , Wieruszewski, Patrick M., Ursoleo, Jacopo D’Andria, Ding, Yuchuan, Elmadhoun, Omar, Sakusic, Amra , Ortoleva, Jamel P. , Wieruszewski, Patrick M. , Ursoleo, Jacopo D’Andria , Elmadhoun, Omar

Mayo Clinic

Brain Circulation | July 16, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.4103/bc.bc_37_26 Get It

Abstract: Extracorporeal membrane oxygenation (ECMO) is increasingly used to support patients with severe cardiac or respiratory failure. Neurological complications occur across ECMO configurations and represent a major contributor to mortality and long-term disability. Major neurological complications include ischemic and hemorrhagic stroke, hypoxic ischemic brain injury, seizures, delirium, spinal cord and peripheral nervous system injury, and brain death. The mechanisms underlying neurological injury during ECMO are multifactorial and are influenced by ECMO configuration, reflecting differences in cerebral perfusion, gas exchange, anticoagulation exposure, and precannulation physiologic insults. This review synthesizes neurological complications associated with ECMO, neurological monitoring, and outcomes.
Intracardiac thrombosis during liver transplantation: A 22-year single-institution cohort study
Pai, Sher‐Lu , Lee, Jennifer Y. , Sher, Taimur , Li, Zhuo , Perry, Dana K. , Logvinov, Ilana I. , Chadha, Ryan , Aniskevich, Stephen , Mao, Shennen A. , Lee, Jennifer , Chadha, Ryan , Pai, Sher-Lu , Aniskevich, Stephen , Mao, Shennen A , Logvinov, Ilana

Mayo Clinic

Liver Transplantation | December 12, 2025 | Volume: 32 | Issue: 4 | Pages: 633-637

10.1097/lvt.0000000000000774 | PMID 41384290 Get It

Outcomes in Asymptomatic Patients Undergoing Coronary Revascularization Before Liver Transplantation
Umadat, Goyal , Lee, Jennifer Y. , Ray, Jordan , Chadha, Ryan , Ma, Yaohua , Sledge, Hanna J., Pungpapong, Surakit , Janik, Leslie E., Pillai, Dilip, Sabbagh, Abdallah El , Pollak, Peter , Gharacholou, S. Michael , Lee, Jennifer , Chadha, Ryan , Michael Gharacholou, S , Pungpapong, Surakit

Mayo Clinic

Journal of Clinical Medicine | October 7, 2025 | Volume: 14 | Issue: 19 | Pages: 7067

10.3390/jcm14197067 | PMID 41096148 Get It

Background: Coronary artery disease (CAD) is common among liver transplantation (LT) candidates, yet whether pre-transplant percutaneous coronary intervention (PCI) improves post-LT outcomes remains uncertain. Methods: We conducted a single-center, Institutional Review Board-approved cohort study of adults undergoing LT from 2005 to 2025. Asymptomatic candidates with significant stenosis on invasive angiography were included; prior coronary artery bypass grafting was excluded. The primary endpoint was major adverse cardiovascular events (MACE: myocardial infarction [MI], stroke/transient ischemic attack, new systolic dysfunction, post-LT coronary revascularization, or all-cause death). Results: Among 111 patients (median age 65 years; 84% male), 66 (59%) underwent PCI and 45 (41%) were managed medically. Over a median 32 months of follow-up, 61 patients (55%) experienced MACE. Composite MACE did not differ between PCI and non-PCI groups (52% vs. 60%, p = 0.40; log-rank p = 0.59). Fine–Gray modeling showed no association of PCI with MACE; independent predictors were prior MI (HR 1.81, 95% CI 1.01–3.24) and pre-transplant dialysis (HR 2.13, 95% CI 1.07–4.24). Major bleeding occurred in 7%. Matched and era-stratified analyses were concordant. Conclusions: In asymptomatic LT candidates with angiographically severe CAD, pre-LT PCI was not associated with a lower incidence of post-LT MACE.
The Minnesota Conference proposed guidelines for education and training in clinical neuropsychology
Stringer, Anthony Y. , Fuchs, Kathleen , Edgar, Veronica Bordes , Correia, Stephen , Penna, Suzanne , Whiteside, Douglas M. , Bodin, Douglas, Butt, Sakina M. , Dodzik, Peter , Fernandes, Mary A. , Freece, Krista, Fuller, Richard, Getz, Glen E., Harder, Lana , Irani, Farzin , Janzen, Laura , Kaseda, Erin T. , Kramer, Megan , Kubu, Cynthia S. , Lafosse, Jose M., Lee-DaRocha, Jennifer, MacDonald, Beatriz , Strutt, Adriana M. , McBride, W.E., Mucci, Grace , Nayar, Kritika , Paltzer, June Yu, Ray, Courtney , Ready, Rebecca E. , Schmitt, Taylor Rose , Rush, Beth , Stanford, Lisa D., Patten, Ryan Van , Verroulx, Kris, Wilson, Jaime, Wright, Ingram , Zartman, Andrea L., Fujii, Daryl , Heffelfinger, Amy , Rey‐Casserly, Celiane , Whiteside, Douglas , Block, Cady, Calamia, Matthew , M Dotson, Vonetta , Johnstone, Brick , Kaseda, Erin , Madore, Michelle , Medina, Luis Daniel , Sperling, Scott , Stiers, William , Stricker, Nikki H , Bilder, Robert , Heffelfinger, Amy , Schmitter-Edgecombe, Maureen , Bristow, Thomas, Reyes, Anny , Block, Cady K. , Calamia, Matthew , Didehbani, Nyaz , Fuller, Richard, Harder, Lana, McBride, Will, Medina, Luis D. , Singh, Shifali M. , Sperling, Scott A. , Stricker, Nikki H. , Thornton, Allen E. , Vandermorris, Susan , Parsons, Thomas D. , Puente, Antonio E. , Roper, Brad L.

Mayo Clinic

The Clinical Neuropsychologist | July 2, 2025 | Volume: 40 | Issue: 2 | Pages: 331-375

10.1080/13854046.2025.2520957 | PMID 40604361 Get It

Four-factor Prothrombin Complex Concentrate During Liver Transplantation: A Retrospective Cohort Study
Lee, Jennifer Y. , Rivero, Andrea , Spaulding, Aaron , Borkar, Shalmali R. , McKenzie, Ian F. C., Davey, Kuki, Ladlie, Beth L., Lee, Jennifer , Borkar, Shalmali, Mckenzie, Ian, Ladlie, Beth, Spaulding, Aaron , Rivero, Andrea, Renew, J. Ross

Mayo Clinic

Transplantation Direct | May 18, 2024 | Volume: 10 | Issue: 6 | Pages: e1637

10.1097/txd.0000000000001637 | PMID 38769975 Get It

Background. Four-factor prothrombin complex concentrate (PCC) is a plasma product that contains factors II, VII, IX, X, protein C, and protein S. PCC can be used off-label to treat coagulopathy during orthotopic liver transplantation (OLT). However, its use comes with safety concerns regarding thrombosis. The purpose of our study is to determine the safety of PCC in OLT. Methods. We conducted a retrospective cohort study of patients who received 4-factor PCC during OLT at our institution from January 1, 2018, to May 1, 2022, with a 1:1 match of 83 patients who received PCC and 83 patients who did not. We evaluated 30-d mortality, 1-y mortality, prevalence of thrombotic complications (portal vein thrombosis, deep venous thrombosis, myocardial infarction, and pulmonary embolus), and postoperative intensive care (ICU) length of stay (LOS). Results. There was no significant difference in 30-d mortality (odds ratio [OR] 5; 95% confidence interval [CI], 0.58-42.8; P = 0.14), 1-y mortality (OR 3; 95% CI, 0.61-14.86; P = 0.18), or ICU LOS (OR –13.8; 95% CI, –39.2 to 11.6; P = 0.29). There was no increased incidence of thrombotic complications among patients receiving PCC 90 d after surgery, including portal vein thrombosis (OR 1.5; 95% CI, 0.42-5.32; P = 0.53), pulmonary embolus (OR 1; 95% CI, 0.14-7.1; P = 0.99), deep venous thrombosis (OR 0.67; 95% CI, 0.11-3.99; P = 0.66), and myocardial infarction (OR 1.67; 95% CI, 0.4-6.97; P = 0.48). Conclusions. Although there was a statistically insignificant increase in mortality after PCC administration during OLT, we did not see a significant increase in perioperative complications, including thrombotic events and increased ICU LOS.
A Post Hoc Analysis of Tolvaptan (TOL) Efficacy and Safety in Slowing Rate of Renal Function Decline in Subjects with Very Late-Stage Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Gansevoort, Ron T. , Chapman, Arlene B., Ouyang, John , Lee, Jennifer , Japes, Hina, Torres, Vicente E. , Perrone, Ronald D. , Wang, Tao

Mayo Clinic

Journal of the American Society of Nephrology | May 17, 2024 | Volume: 31 | Issue: 10S | Pages: 490-490

10.1681/asn.20203110s1490c Get It

1530: THE ASSOCIATION OF TEMPORARY PACEMAKER SETTINGS ON ICU LENGTH OF STAY AFTER HEART TRANSPLANTATION
Lee, Jennifer , Gharacholou, S. Michael , Patel, Parag, Yip, Daniel , Leoni, Juan , Lyle, Melissa , Nativí, Jose, Umadat, Goyal , Rice, Bria , Leoni, Juan Carlos , Goswami, Rohan

Mayo Clinic

Critical Care Medicine | December 14, 2023 | Volume: 52 | Issue: 1 | Pages: S736-S736

10.1097/01.ccm.0001004276.95645.13 Get It

Major Publications in the Critical Care Pharmacotherapy Literature: 2022
Gurnani, Payal K. , Barlow, Brooke , Busse, Laurence W. , Ford, Jenna , Gibson, Gabrielle , Lee, Jennifer , Rivosecchi, Ryan , Spezzano, Katherine , Thornton, Nathan, Vallabhajosyula, Saraschandra , Wieruszewski, Patrick M. , Vallabhajosyula, Saraschandra , Wieruszewski, Patrick M , Boling, Bryan , Díaz‐Gómez, José L. , Khanna, Ashish K. , Thornton, Nathan, Witenko, Corey J.

Mayo Clinic

Critical Care Explorations | September 25, 2023 | Volume: 5 | Issue: 10 | Pages: e0981

10.1097/cce.0000000000000981 | PMID 37753239 Get It

OBJECTIVES: A number of trials related to critical care pharmacotherapy were published in 2022. We aimed to summarize the most influential publications related to the pharmacotherapeutic care of critically ill patients in 2022. DATA SOURCES: PubMed/Medical Literature Analysis and Retrieval System Online and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. STUDY SELECTION: Randomized controlled trials, prospective studies, or systematic review/meta-analyses of adult critically ill patients assessing a pharmacotherapeutic intervention and reporting clinical endpoints published between January 1, 2022, and December 31, 2022, were included in this article. DATA EXTRACTION: Articles from a systematic search and the Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update were included and stratified into clinical domains based upon consistent themes. Consensus was obtained on the most influential publication within each clinical domain utilizing an a priori defined three-round modified Delphi process with the following considerations: 1) overall contribution to scientific knowledge and 2) novelty to the literature. DATA SYNTHESIS: The systematic search and Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update yielded a total of 704 articles, of which 660 were excluded. The remaining 44 articles were stratified into the following clinical domains: emergency/neurology, cardiovascular, gastroenterology/fluids/nutrition, hematology, infectious diseases/immunomodulation, and endocrine/metabolic. The final article selected from each clinical domain was summarized following a three-round modified Delphi process and included three randomized controlled trials and three systematic review/meta-analyses. Article topics summarized included dexmedetomidine versus other sedatives during mechanical ventilation, beta-blocker treatment in the critically ill, restriction of IV fluids in septic shock, venous thromboembolism prophylaxis in critically ill adults, duration of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia, and low-dose methylprednisolone treatment in severe community-acquired pneumonia. CONCLUSIONS: This concise review provides a perspective on articles published in 2022 that are relevant to the pharmacotherapeutic care of critically ill patients and their potential impact on clinical practice.
Preemptive Venoarterial Extracorporeal Membrane Oxygenation for Liver Transplantation—Judicious Candidate Selection
Lee, Jennifer , Allen, Wesley L. , Scott, Courtney L. , Aniskevich, Stephen , Aniskevich, Stephen , Pai, Sher‐Lu

Mayo Clinic

Journal of Clinical Medicine | July 28, 2023 | Volume: 12 | Issue: 15 | Pages: 4965

10.3390/jcm12154965 | PMID 37568367 Get It

Portopulmonary hypertension is a relatively common pathologic condition in patients with end-stage liver disease. Traditionally, severe pulmonary hypertension is regarded as a contraindication to liver transplantation (LT) due to a high perioperative mortality rate. Recently, extracorporeal membrane oxygenation (ECMO) has been utilized for intraoperative management of LT. As venoarterial (VA) ECMO may benefit certain high-risk LT patients by reducing the ventricular workload by the equivalent of the programmed flow rate, its usage requires multidisciplinary planning with considerations of the associated complications. We highlighted two cases at our single-center institution as examples of high-risk pulmonary hypertension patients undergoing LT on planned VA ECMO. These patients both survived the intraoperative period; however, they had drastically different postoperative outcomes, generating discussions on the importance of judicious patient selection. Since ECMO has removed the barrier of intraoperative survivability, the patient selection process may need to put weight on the patient’s potential for postoperative recovery and rehabilitation. Considerations on LT recipients undergoing preemptive ECMO need to expand from the ability of the patients to withstand the demands of the surgery during the immediate perioperative period to the long-term postoperative recovery course.
Gender disparity in the effects of COVID‐19 on academic productivity and career satisfaction in anesthesiology in the US: Results of a national survey of anesthesiologists
Jankowska, Anna , Pai, Sher‐Lu , Lee, Jennifer K. , Nyshadham, Soumya, Diachun, Carol Ann B., Byerly, Stephanie I., Hertzberg, Linda B., Berenstain, Laura K. , Pai, Sher-Lu , Austin, Thomas M.

Mayo Clinic

Gender, Work & Organization | June 12, 2023 | Volume: 30 | Issue: 5 | Pages: 1741-1758

10.1111/gwao.13016 Get It

AbstractThe coronavirus disease 2019 (COVID‐19) pandemic created unprecedented challenges for anesthesiologists both at work and home. This study examined whether the pandemic affected academic productivity and career satisfaction among anesthesiologists practicing in the United States during the early stages of the pandemic and whether these effects differed by gender. A survey was emailed to 25,473 members of the American Society of Anesthesiologists to learn about their experiences during the beginning of the pandemic. The survey directed respondents to rate their change in academic productivity, clinical care hours, scholarly and leadership opportunities, income, childcare duties, and household responsibilities during the first 5 months of the pandemic (March 1–July 31, 2020). The primary variable was gender, academic productivity was the primary outcome, and data were analyzed by multivariable proportional odds logistic regression models and correlations. Female anesthesiologists reported lower academic productivity and career satisfaction relative to male anesthesiologists during the study period. Career satisfaction positively correlated with academic productivity. Compared to male anesthesiologists, female anesthesiologists also had more household responsibilities before and during the pandemic. Being a female parent reduced academic productivity relative to that reported by nonparents of either gender. In conclusion, the early months of the COVID‐19 pandemic had a greater adverse professional impact on female anesthesiologists than on their male counterparts. Efforts to support and retain female anesthesiologists, particularly those early in their careers and those with children, are essential for the specialty to maintain its workforce and promote gender equity in promotion and leadership.